A real-world study of sorafenib and lenvatinib: A retrospective review of multikinase inhibitor therapies for hepatocellular carcinoma in an Australian tertiary treatment center

被引:0
|
作者
Patwala, K. [1 ]
Alam, W. [1 ]
Ng, S. [1 ]
O'Neill, P. [1 ]
Mishra, G. [1 ]
Bell, S. [1 ]
Dev, A. [1 ,2 ]
机构
[1] Monash Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
368
引用
收藏
页码:97 / 98
页数:2
相关论文
共 50 条
  • [31] The real-world systemic sequential therapy of sorafenib and regorafenib for advanced hepatocellular carcinoma: a multicenter retrospective study in Korea
    Lee, Yoonseok
    Chang, Sung Won
    Lee, Min-Jin
    Kim, Ji Hoon
    Bang, Soo Min
    Kim, Sehwa
    Lee, Young-Sun
    Cho, Sung Bum
    Seo, Yeon Seok
    Yim, Hyung Joon
    Hwang, Sang Youn
    Lee, Hyun Woong
    Chang, Young
    Jang., Jae Young
    JOURNAL OF HEPATOLOGY, 2020, 73 : S909 - S909
  • [32] Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
    Zhu, Yun
    Sun, Penghui
    Wang, Kunyuan
    Xiao, Shuzhe
    Cheng, Yanling
    Li, Xiangzhao
    Wang, Biao
    Li, Jiancong
    Yu, Wenxuan
    Cheng, Yang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [33] Efficacy and safety of lenvatinib monotreatment and lenvatinib-based combination therapy for patients with unresectable hepatocellular carcinoma: a retrospective, real-world study in China
    Yun Zhu
    Penghui Sun
    Kunyuan Wang
    Shuzhe Xiao
    Yanling Cheng
    Xiangzhao Li
    Biao Wang
    Jiancong Li
    Wenxuan Yu
    Yang Cheng
    Cancer Cell International, 21
  • [34] Real-World Effectiveness of Lenvatinib in Hepatocellular Carcinoma Patients with Nonalcoholic Steatohepatitis
    Singal, Amit G.
    Nagar, Saurabh P.
    Hitchens, Abby
    Davis, Keith L.
    Iyer, Shrividya
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (03)
  • [35] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Shuntaro Obi
    Takahisa Sato
    Shinpei Sato
    Miho Kanda
    Yuta Tokudome
    Yuichiro Kojima
    Yoji Suzuki
    Kenji Hosoda
    Toshihiro Kawai
    Yuji Kondo
    Yoshihiro Isomura
    Hiroshi Ohyama
    Keiko Nakagomi
    Hiroshi Ashizawa
    Yuko Miura
    Hiroyuki Amano
    Hitoshi Mochizuki
    Masao Omata
    Hepatology International, 2019, 13 : 199 - 204
  • [36] The efficacy and safety of lenvatinib for advanced hepatocellular carcinoma in a real-world setting
    Obi, Shuntaro
    Sato, Takahisa
    Sato, Shinpei
    Kanda, Miho
    Tokudome, Yuta
    Kojima, Yuichiro
    Suzuki, Yoji
    Hosoda, Kenji
    Kawai, Toshihiro
    Kondo, Yuji
    Isomura, Yoshihiro
    Ohyama, Hiroshi
    Nakagomi, Keiko
    Ashizawa, Hiroshi
    Miura, Yuko
    Amano, Hiroyuki
    Mochizuki, Hitoshi
    Omata, Masao
    HEPATOLOGY INTERNATIONAL, 2019, 13 (02) : 199 - 204
  • [37] Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis
    Cheon, Jaekyung
    Chon, Hong Jae
    Bang, Yeonghak
    Park, Neung Hwa
    Shin, Jung Woo
    Kim, Kang Mo
    Lee, Han Chu
    Lee, Jooho
    Yoo, Changhoon
    Ryoo, Baek-Yeol
    LIVER CANCER, 2020, 9 (05) : 613 - 624
  • [38] Correspondence to letter to the editor on "Sorafenib vs. lenvatinib in advanced hepatocellular carcinoma after atezolizumab/bevacizumab failure: a real-world study"
    Chon, Young Eun
    Kim, Dong Yun
    Chon, Hong Jae
    Kim, Do Young
    CLINICAL AND MOLECULAR HEPATOLOGY, 2025, 31 (01)
  • [39] Real-world efficacy and safety of lenvatinib in Korean patients with advanced hepatocellular carcinoma: A multicenter retrospective analysis
    Cheon, J.
    Yoo, C.
    Bang, Y.
    Chon, H.
    Ryoo, B-Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1308 - S1308
  • [40] Real-world experience with Lenvatinib in the management of Hepatocellular Carcinoma: A single-center Indian experience.
    Rauthan, Amit
    Somashekhar, S. P.
    Patil, Poonam
    Zaveri, Shabber
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)